blog

Artificial intelligence, or AI, has been on the radar screen as a possible tool to improve drug development, and clinical trial design and conduct for some time. This month's blog covers some of the advancements.

Adverse drug reactions caused by individual drugs and drug combinations contribute to one of the top 10 causes of death in the United States. This blog offers insight on minimizing the risks with DDI studies.

In part 1 of this series, we discussed how gut bacteria affect your health. In this article, we offer some strategies for maintaining a healthy microbiota, from reputable sources, supported by science.

Research increasingly supports the idea that your gut bacteria are tied to your probability of intestinal disorders and other conditions, like diabetes, obesity, depression, and colon cancer. In this month's blog, we offer an oversight o

In our February 3rd blog, we discussed the difference between genetics and genomics. Today, we focus on the advances being made in medicine that are affected or influenced by the increased understanding of the human genome.

Get to know Ingrid Holmes, Vice President of Global Clinical Operations at Altasciences.